GALECTIN THERAPEUTICS INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-16.2M | $-21.4M | $-20.0M | $-15.8M | $-12.1M | $-9.7M | $-10.9M | $-5.6M |
| Depreciation & Amortization | $1.0K | $7.0K | $7.0K | $10.0K | $12.0K | $9.0K | $9.0K | $12.0K |
| Depreciation | — | — | — | — | — | $3.0K | $6.0K | — |
| Amortization | $1.0K | $7.0K | $7.0K | $8.0K | $7.0K | $6.0K | $3.0K | — |
| Stock-Based Compensation | $1.1M | $2.5M | $3.4M | $4.1M | $3.8M | $2.8M | $3.2M | $1.9M |
| Net Cash from Operating Activities | $-15.9M | $-16.4M | $-17.0M | $-12.4M | $-7.5M | $-7.5M | $-5.7M | $-3.1M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | $0 | $0 | $0 | $5.0K | $5.0K | — |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $0 | — | — | — | — | $64.0K | $-15.0K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $3.6M | — | — | — | $8.6M | $10.4M | $6.2M | $8.7M |
| Net Change in Cash | $-12.3M | $-10.5M | $-3.3M | $18.6M | $1.1M | $3.0M | $506.0K | $5.6M |
| Free Cash Flow | — | — | $-17.0M | $-12.4M | $-7.5M | $-7.5M | $-5.7M | — |